Skip to main content
logo
Bliss GVS Pharma Limited (BOM:506197)
India flag India · Delayed Price · Currency is INR
153.70
-3.35 (-2.13%)
At close: Jan 21, 2026

Bliss GVS Pharma Revenue

Bliss GVS Pharma had revenue of 2.44B INR in the quarter ending September 30, 2025, with 12.27% growth. This brings the company's revenue in the last twelve months to 8.60B, up 7.51% year-over-year. In the fiscal year ending March 31, 2025, Bliss GVS Pharma had annual revenue of 8.10B with 5.13% growth.

Revenue (ttm)
8.60B
Revenue Growth
+7.51%
P/S Ratio
1.99
Revenue / Employee
8.91M
Employees
966
Market Cap
17.13B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20258.10B394.81M5.13%
Mar 31, 20247.70B186.57M2.48%
Mar 31, 20237.52B41.33M0.55%
Mar 31, 20227.47B1.70B29.50%
Mar 31, 20215.77B-1.12B-16.26%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Unichem Laboratories22.26B
Morepen Laboratories17.56B
Hikal16.99B
TTK Healthcare8.25B
Venus Remedies6.99B
Fermenta Biotech5.63B
Syncom Formulations (India)5.15B
Amrutanjan Health Care4.70B
Revenue Rankings

Bliss GVS Pharma News

More News